MMI-0100: Phase I started

Moerae Matrix began a double-blind, placebo-controlled, Dutch Phase I trial to evaluate ascending doses of inhaled MMI-0100 in up to 48 healthy volunteers. MMI-0100 uses MicroDose’s inhaler technology...